Platinum Health's Klein takes over Elements addiction-treatment firm

David O. Klein - Managing Partner - Klein Moynihan Turco LLP

Platinum Health's Klein takes over Elements addiction-treatment firm

Synthesis and clinical application of new drugs approved by FDA in 2023 - ScienceDirect

Pharmaceutics, Free Full-Text

Frontiers Bidirectional Mechanical Response Between Cells and Their Microenvironment

May 2022 – The Pulse – Powered by Duke Heart

Rare Disease Community Statement on Drug Pricing Policy Priorities

Biden-McCarthy Debt Ceiling Meeting: Debt Limit Meeting Ends Without a Breakthrough - The New York Times

Codeage Eyes Vitamins AREDS 2 Formula Supplement, Lutein, Zeaxanthin

Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets - Modern Pathology

There's A Lot of Growth in That Industry': Addiction Treatment Viewed as Behavioral Health's Top Expansion Area - Behavioral Health Business

Frontiers Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia

A critical review of palladium organometallic anticancer agents - ScienceDirect